We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$101B
AUM Growth
+$7.34B
Cap. Flow
+$1.66B
Cap. Flow %
1.64%
Top 10 Hldgs %
46.22%
Holding
3,356
New
297
Increased
1,847
Reduced
923
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 6.32%
2 Financials 3.12%
3 Consumer Discretionary 1.83%
4 Healthcare 1.8%
5 Industrials 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYLN icon
3126
Hyliion Holdings
HYLN
$663M
$29.3K ﹤0.01%
+11,804
New +$23.8K
RGTI icon
3127
Rigetti Computing
RGTI
$4.7B
$29.2K ﹤0.01%
37,340
+200
+0.5% +$183
CVM icon
3128
CEL-SCI Corp
CVM
$20.6M
$29.1K ﹤0.01%
917
+34
+4% +$1.2K
NUVB icon
3129
Nuvation Bio
NUVB
$2.24B
$28.9K ﹤0.01%
12,640
-9,537
-43% -$29.1K
EMX
3130
DELISTED
EMX Royalty
EMX
$28.4K ﹤0.01%
15,945
TSHA icon
3131
Taysha Gene Therapies
TSHA
$1.59B
$28.4K ﹤0.01%
+14,118
New +$31K
NXDR
3132
Nextdoor Holdings
NXDR
$835M
$28.4K ﹤0.01%
+11,440
New +$29.4K
VRCA icon
3133
Verrica Pharmaceuticals
VRCA
$86.2M
$27.6K ﹤0.01%
1,902
-1,090
-36% -$49.1K
SSKN
3134
DELISTED
Strata Skin Sciences
SSKN
$27.5K ﹤0.01%
10,016
PGEN icon
3135
Precigen
PGEN
$1.93B
$27.5K ﹤0.01%
28,984
-7,932
-21% -$10K
RGLS
3136
DELISTED
Regulus Therapeutics
RGLS
$25.9K ﹤0.01%
+16,466
New +$27.2K
BIAF icon
3137
bioAffinity Technologies
BIAF
$4.15M
$25.2K ﹤0.01%
403
-17
-4% -$1.02K
HITI
3138
High Tide
HITI
$189M
$24.3K ﹤0.01%
11,859
CNF
3139
CNFinance Holdings
CNF
$40.3M
$24.1K ﹤0.01%
1,932
PSNY icon
3140
Polestar Automotive Holding UK
PSNY
$1.98B
$23.7K ﹤0.01%
459
+34
+8% +$1.1K
DOUG icon
3141
Douglas Elliman
DOUG
$155M
$22.8K ﹤0.01%
12,451
+427
+4% +$732
GROY icon
3142
Gold Royalty Corp
GROY
$593M
$22.8K ﹤0.01%
16,738
LCTX icon
3143
Lineage Cell Therapeutics
LCTX
$257M
$21.9K ﹤0.01%
24,172
AKTS
3144
DELISTED
Akoustis Technologies Inc
AKTS
$21.8K ﹤0.01%
243,741
LGVN
3145
Longeveron
LGVN
$19M
$21.7K ﹤0.01%
11,200
NMG
3146
Nouveau Monde Graphite
NMG
$415M
$21.3K ﹤0.01%
13,588
GSAT icon
3147
Globalstar
GSAT
$10.2B
$20.1K ﹤0.01%
1,081
-454
-30% -$8.4K
FCEL icon
3148
FuelCell Energy
FCEL
$1.7B
$20K ﹤0.01%
1,753
+1
+0.1% +$15
MIST icon
3149
Milestone Pharmaceuticals
MIST
$144M
$19.9K ﹤0.01%
13,080
BBAI icon
3150
BigBear.ai
BBAI
$1.32B
$18.1K ﹤0.01%
12,363
-330
-3% -$487

Similar funds

Creative Planning's Q3 2024 Portfolio in Review

As of Q3 2024, Creative Planning held 3,356 positions worth $101B, up 7.8% from $93.7B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning's Q3 2024 filing shows 297 new, 1,847 increased, 923 reduced and 172 closed positions. Its largest new stake was Evertec: 44,581 shares worth $1.51M. The largest sale was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $176M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q3 2024 buy was Evertec: 44,581 shares worth $1.51M.
  • Creative Planning added most to Vanguard Total Bond Market in Q3 2024, an estimated $536M increase.
  • Creative Planning's biggest Q3 2024 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $176M.
  • Creative Planning fully exited Encore Wire Corp in Q3 2024, selling an estimated $4.28M.
  • Creative Planning's ten largest holdings make up 46% of its $101B portfolio in Q3 2024.
  • Creative Planning opened 297 new positions and closed 172 in Q3 2024.
  • Creative Planning's portfolio value rose 7.8% quarter-over-quarter to $101B.

Based on Creative Planning's 13F filing for Q3 2024, filed 11 Oct 2024.